<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Batchu N</submitter><funding>NIAID NIH HHS</funding><funding>NHLBI NIH HHS</funding><pagination>1638-1646</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5096552</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>36(8)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>Survival of immune and nonimmune cells relies on Axl, a receptor tyrosine kinase, which is implicated in hypertension. Activated T lymphocytes are involved in regulation of high blood pressure. The goal of the study was to investigate the role of Axl in T-lymphocyte functions and its contribution to salt-dependent hypertension.&lt;h4>Approach and results&lt;/h4>We report increased apoptosis in peripheral blood from Axl(-/-) mice because of lower numbers of white blood cells mostly lymphocytes. In vitro studies showed modest reduction in interferon gamma production in Axl(-/-) type 1 T helper cells. Axl did not affect basic proliferation capacity or production of interleukin 4 in Axl(-/-) type 2 T helper cells. However, competitive repopulation of Axl(-/-) bone marrow or adoptive transfer of Axl(-/-) CD4(+) T cells to Rag1(-/-) mice showed robust effect of Axl on T lymphocyte expansion in vivo. Adoptive transfer of Axl(-/-) CD4(+) T cells was protective in a later phase of deoxycorticosterone-acetate and salt hypertension. Reduced numbers of CD4(+) T cells in circulation and in perivascular adventitia decreased vascular remodeling and increased vascular apoptosis in the late phase of hypertension.&lt;h4>Conclusions&lt;/h4>These findings suggest that Axl is critical for survival of T lymphocytes, especially during vascular remodeling in hypertension.</pubmed_abstract><journal>Arteriosclerosis, thrombosis, and vascular biology</journal><pubmed_title>Role of Axl in T-Lymphocyte Survival in Salt-Dependent Hypertension.</pubmed_title><pmcid>PMC5096552</pmcid><funding_grant_id>P01 AI102851</funding_grant_id><funding_grant_id>R01 AI072690</funding_grant_id><funding_grant_id>R01 HL105623</funding_grant_id><funding_grant_id>R01 HL124018</funding_grant_id><pubmed_authors>Wadosky KM</pubmed_authors><pubmed_authors>Morrell CN</pubmed_authors><pubmed_authors>Fowell DJ</pubmed_authors><pubmed_authors>Batchu N</pubmed_authors><pubmed_authors>Korshunov VA</pubmed_authors><pubmed_authors>Hughson A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Role of Axl in T-Lymphocyte Survival in Salt-Dependent Hypertension.</name><description>&lt;h4>Objective&lt;/h4>Survival of immune and nonimmune cells relies on Axl, a receptor tyrosine kinase, which is implicated in hypertension. Activated T lymphocytes are involved in regulation of high blood pressure. The goal of the study was to investigate the role of Axl in T-lymphocyte functions and its contribution to salt-dependent hypertension.&lt;h4>Approach and results&lt;/h4>We report increased apoptosis in peripheral blood from Axl(-/-) mice because of lower numbers of white blood cells mostly lymphocytes. In vitro studies showed modest reduction in interferon gamma production in Axl(-/-) type 1 T helper cells. Axl did not affect basic proliferation capacity or production of interleukin 4 in Axl(-/-) type 2 T helper cells. However, competitive repopulation of Axl(-/-) bone marrow or adoptive transfer of Axl(-/-) CD4(+) T cells to Rag1(-/-) mice showed robust effect of Axl on T lymphocyte expansion in vivo. Adoptive transfer of Axl(-/-) CD4(+) T cells was protective in a later phase of deoxycorticosterone-acetate and salt hypertension. Reduced numbers of CD4(+) T cells in circulation and in perivascular adventitia decreased vascular remodeling and increased vascular apoptosis in the late phase of hypertension.&lt;h4>Conclusions&lt;/h4>These findings suggest that Axl is critical for survival of T lymphocytes, especially during vascular remodeling in hypertension.</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Aug</publication><modification>2025-04-18T20:50:10.403Z</modification><creation>2019-03-27T02:28:17Z</creation></dates><accession>S-EPMC5096552</accession><cross_references><pubmed>27365404</pubmed><doi>10.1161/ATVBAHA.116.307848</doi><doi>10.1161/atvbaha.116.307848</doi></cross_references></HashMap>